AP-101 holds promise for some with ALS, topline data show
A year of treatment with AP-101 led to positive results for patients in a Phase 2 clinical trial, topline data showed.| ALS News Today
A year of treatment with AP-101 led to positive results for patients in a Phase 2 clinical trial, topline data showed.| ALS News Today
